Filtered By:
Condition: Pain
Vaccination: Influenza Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 72 results found since Jan 2013.
A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults
CONCLUSION: This study demonstrated the non-inferiority of the immunogenicity of a single-dose of Instituto Butantan versus a single dose of the Sanofi Pasteur Seasonal Trivalent Influenza Vaccine in adults. Both vaccines were well tolerated and presented similar safety profiles.PMID:37121800 | DOI:10.1016/j.vaccine.2023.04.050
Source: Vaccine - April 30, 2023 Category: Allergy & Immunology Authors: Tazio Vanni Maria da Gra ça Salomão Juliana Yukari Kodaira Viscondi Patr ícia Emilia Braga Anderson da Silva Roberta de Oliveira Piorelli Joane do Prado Santos Vera L úcia Gattás Maria Beatriz Bastos Lucchesi Mayra Martho Moura de Oliveira Marcelo Ei Source Type: research
Shoulder Pain Following Influenza Vaccine Administration: A Clinical Vignette
Am J Phys Med Rehabil. 2023 Mar 21. doi: 10.1097/PHM.0000000000002242. Online ahead of print.NO ABSTRACTPMID:37026846 | DOI:10.1097/PHM.0000000000002242
Source: Health Physics - April 7, 2023 Category: Physics Authors: Evan R Zeldin Deanna Boyette John W Norbury Source Type: research
COVID-19 (Omicron strain) hospital admissions from a virtual ward - who required further care?
CONCLUSIONS: Few patients required admission from the virtual ward in the setting of the Omicron variant (BA.1, BA.2) as a direct result of COVID-19 disease and virtual ward care. Shortness of breath and chest pain were the most common symptoms driving further clinical care.PMID:36991540 | PMC:PMC10040950 | DOI:10.1111/irv.13108
Source: Respiratory Care - March 30, 2023 Category: Respiratory Medicine Authors: Ian Mackay Megan France Duncan McAuley Sean Wing Mary Wheeldon Susan Britton Catherine Todd Alexandra Pitiris Leah Barrett-Beck Elizabeth Rushbrook Cameron Bennett Kate McCarthy Source Type: research
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial
CONCLUSIONS: Immune responses after coadministration of PCV20 and QIV were noninferior to separate administration of either vaccine. The PCV20 safety profile was similar when given together with or after QIV. These findings support PCV20 and QIV coadministration.TRIAL REGISTRATION: ClinicalTrials.gov, NCT04526574.PMID:36828719 | DOI:10.1016/j.vaccine.2022.11.046
Source: Vaccine - February 24, 2023 Category: Allergy & Immunology Authors: Kevin Cannon Jose F Cardona Kari Yacisin Allison Thompson Todd J Belanger Dung-Yang Lee Yahong Peng Lisa Moyer John Ginis William C Gruber Daniel A Scott Wendy Watson Source Type: research
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022
DISCUSSION: This review of reports to VAERS following co-administration of mRNA COVID-19 and seasonal influenza vaccines did not reveal any unusual or unexpected patterns of AEs. Increased reporting of certain events (e.g., COVID-19 disease) was expected. CDC will continue to monitor the safety of co-administration of mRNA COVID-19 and seasonal influenza vaccines, including co-administration involving bivalent mRNA COVID-19 booster vaccines that have been recommended for people ages ≥ 6 months in the United States.PMID:36669964 | DOI:10.1016/j.vaccine.2022.12.069
Source: Vaccine - January 20, 2023 Category: Allergy & Immunology Authors: Pedro L Moro Bicheng Zhang Carol Ennulat Margaret Harris Rachel McVey Gina Woody Paige Marquez Michael M McNeil John R Su Source Type: research
Investigation on the hesitancy of COVID-19 vaccination among liver transplant recipients: A cross-sectional study in China
CONCLUSION: For liver transplant recipients, COVID-19 vaccine is an important preventive measure. Identifying the factors influencing COVID-19 vaccine hesitancy is therefore critical to developing a promotion plan. Our study shows that more comprehensive vaccine knowledge popularization and relevant medical workers' training can effectively improve the acceptance of COVID-19 vaccine in this population.PMID:36589975 | PMC:PMC9797997 | DOI:10.3389/fpubh.2022.1014942
Source: Pain Physician - January 2, 2023 Category: Anesthesiology Authors: Yixiao Pan Shiming Gong Xinye Zhu Chuqing Xue Yilei Jing Yinghua Sun Yongbing Qian Jianjun Zhang Qiang Xia Source Type: research
Fight Aging! Newsletter, January 2nd 2023
In conclusion, circulating monocytes in older adults exhibit increased expression of activation, adhesion, and migration markers, but decreased expression of co-inhibitory molecules.
MERTK Inhibition Increases Bone Density via Increased Osteoblast Activity
https://www.fightaging.org/archives/2022/12/mertk-inhibition-increases-bone-density-via-increased-osteoblast-activity/
Bone density results from the balance of constant activity on the part of osteoblasts and osteoclasts, the former building bone, the latter breaking it down. With advancing age, the balance of activity shifts to favor osteoclasts, prod...
Source: Fight Aging! - January 1, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting
Curr Pain Headache Rep. 2022 Nov 23. doi: 10.1007/s11916-022-01094-y. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: The aim of this review is to characterize headache as a vaccine adverse event (VAE) in clinical trials.RECENT FINDINGS: Of the recent phase III vaccine RCTs (non-COVID-19), 53 studies reported on headache (13 infectious agents). The median rate (interquartile range) of headache was 15.6% (IQR: 9.6-37.6%). Of these, 24.5% of the RCTs reported headache greater in the vaccine group compared to the placebo/control group. In the herpes zoster vaccination trials, headache was more common in all active groups: me...
Source: Herpes - November 23, 2022 Category: Infectious Diseases Authors: Kimberly N Garces Alexandra N Cocores Peter J Goadsby Teshamae S Monteith Source Type: research
Probiotics for preventing acute upper respiratory tract infections
CONCLUSIONS: Overall, we found that probiotics were better than placebo or no treatment in preventing acute URTIs.PMID:36001877 | DOI:10.1002/14651858.CD006895.pub4
Source: Cochrane Database of Systematic Reviews - August 24, 2022 Category: General Medicine Authors: Yunli Zhao Bi Rong Dong Qiukui Hao Source Type: research
Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination
CONCLUSION: SIRVA should be regarded as an under-reported, significant cause of post-vaccination morbidity. In the setting of COVID-19 mass vaccination, clinicians must be aware of signs and symptoms of SIRVA as well as appropriate diagnostic modalities and treatment options. Additionally, standardization and proper education regarding injection technique and appropriate needle length is imperative to reducing harm.PMID:35817645 | DOI:10.1016/j.vaccine.2022.06.002
Source: Vaccine - July 11, 2022 Category: Allergy & Immunology Authors: Jessica R Bass Gregory A Poland Source Type: research
